Immunobiological barriers to xenotransplantation

International Journal of Surgery

Volumn 23, Issue , 2015, Pages 211-216

  Cooper, David K C ^a   Ekser, Burcin ^b   Tector, A Joseph ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Organ donation; Pig; Transplantation, islets; Transplantation, organs; Xenotransplantation

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NONGAL ANTIBODY; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACUTE HUMORAL XENOGRAFT REJECTION; BLOOD CLOTTING DISORDER; CELL XENOTRANSPLANTATION; CELLULAR IMMUNITY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VASCULOPATHY; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOBIOLOGY; INFLAMMATION; NONHUMAN; ORGAN TRANSPLANTATION; ORGAN XENOTRANSPLANTATION; PIG; PRIMATE; PRIORITY JOURNAL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TISSUE XENOTRANSPLANTATION; VASCULAR DISEASE; XENOTRANSPLANTATION; ADVERSE EFFECTS; ANIMAL; BLOOD CLOTTING; GENETICS; GRAFT SURVIVAL; IMMUNOLOGY; TRANSGENIC ANIMAL; TRANSPLANTATION; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES; BLOOD COAGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTS;

EID: 84951573696     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.06.068     Document Type: Review

References (59)

1. Lexer G., Cooper D.K., Rose A.G., Wicomb W.N., Rees J., Keraan M., et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J. Heart Transpl. 1986, 5:411-418.
2. Cooper D.K., Human P.A., Lexer G., Rose A.G., Rees J., Keraan M., et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J. Heart Transpl. 1988, 7:238-246.
3. Alexandre G.P.J., Gianello P., Latinne D., Carlier M., Dewaele A., van Obbergh L. Plasmapheresis and splenectomy in experimental renal xenotransplantation. Xenograft 25 1989, 259-266. Excerpta Medica, Amsterdam, New York, Oxford. M. Hardy (Ed.).
4. Rose A.G., Cooper D.K., Human P.A., Reichenspurner H., Reichart B. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J. Heart Lung Transpl. 1991, 10:223-234.
5. Rose A.G., Cooper D.K. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000, 7:31-41.
6. Kobayashi T., Cooper D.K. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Subcell. Biochem. 1999, 32:229-257.
7. Galili U. Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope. Subcell. Biochem. 1999, 32:1-23.
8. Rood P.P., Tai H.C., Hara H., Long C., Ezzelarab M., Lin Y.J., et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transpl. Int. 2007, 20:1050-1058.
9. Dons E.M., Montoya C., Long C.E., Hara H., Echeverri G.J., Ekser B., et al. T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons. Transplantation 2012, 93:769-776.
10. Galili U., Mandrell R.E., Hamadeh R.M., Shohet S.B., Griffiss J.M. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 1988, 56:1730-1737.
11. Stussi G., West L., Cooper D.K., Seebach J.D. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation 2006, 13:390-399.
12. Taniguchi S., Neethling F.A., Korchagina E.Y., Bovin N., Ye Y., Kobayashi T., et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 1996, 62:1379-1384.
13. Ye Y., Neethling F.A., Niekrasz M., Koren E., Richards S.V., Martin M., et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994, 58:330-337.
14. Simon P.M., Neethling F.A., Taniguchi S., Goode P.L., Zopf D., Hancock W.W., et al. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998, 65:346-353.
15. Leventhal J.R., Sakiyalak P., Witson J., Simone P., Matas A.J., Bolman R.M., et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1994, 57:974-978.
16. Kobayashi T., Taniguchi S., Neethling F.A., Rose A.G., Hancock W.W., Ye Y., et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997, 64:1255-1261.
17. Dalmasso A.P., Vercellotti G.M., Platt J.L., Bach F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991, 52:530-533.
18. White D.J., Oglesby T., Liszewski M.K., Tedja I., Hourcade D., Wang M.W., et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transpl. Int. 1992, 5(Suppl. 1):S648-S650.
19. Lambrigts D., Sachs D.H., Cooper D.K. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998, 66:547-561.
20. Cooper D.K., Koren E., Oriol R. Genetically engineered pigs. Lancet 1993, 342:682-683.
21. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003, 299:411-414.
22. Kolber-Simonds D., Lai L., Watt S.R., Denaro M., Arn S., Augenstein M.L., et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7335-7340.
23. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 2005, 11:29-31.
24. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 2005, 11:32-34.
25. Gollackner B., Goh S.K., Qawi I., Buhler L., Knosalla C., Daniel S., et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004, 77:1735-1741.
26. Hara H., Long C., Lin Y.J., Tai H.C., Ezzelarab M., Ayares D., et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl. Int. 2008, 21:1163-1174.
27. McGregor C.G., Ricci D., Miyagi N., Stalboerger P.G., Du Z., Oehler E.A., et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012, 93:686-692.
28. Buhler L., Awwad M., Basker M., Gojo S., Watts A., Treter S., et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000, 69:2296-2304.
29. Cozzi E., Vial C., Ostlie D., Farah B., Chavez G., Smith K.G., et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003, 10:300-310.
30. McGregor C.G., Davies W.R., Oi K., Teotia S.S., Schirmer J.M., Risdahl J.M., et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J. Thorac. Cardiovasc Surg. 2005, 130:844-851.
31. Satyananda V., Hara H., Ezzelarab M.B., Phelps C., Ayares D., Cooper D.K. New concepts of immune modulation in xenotransplantation. Transplantation 2013, 96:937-945.
32. Phelps C.J., Ball S.F., Vaught T.D., Vance A.M., Mendicino M., Monahan J.A., et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009, 16:477-485.
33. Hara H., Witt W., Crossley T., Long C., Isse K., Fan L., et al. Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology 2013, 140:39-46.
34. Reyes L.M., Estrada J.L., Wang Z.Y., Blosser R.J., Smith R.F., Sidner R.A., et al. Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease. J. Immunol. 2014, 193:5751-5757.
35. Robson S.C., Cooper D.K., d'Apice A.J. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000, 7:166-176.
36. Cowan P.J., Robson S.C., d'Apice A.J. Controlling coagulation dysregulation in xenotransplantation. Curr. Opin. Organ Transpl. 2011, 16:214-221.
37. Buhler L., Basker M., Alwayn I.P., Goepfert C., Kitamura H., Kawai T., et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000, 70:1323-1331.
38. Houser S.L., Kuwaki K., Knosalla C., Dor F.J., Gollackner B., Cheng J., et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004, 11:416-425.
39. Lin C.C., Ezzelarab M., Shapiro R., Ekser B., Long C., Hara H., et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am. J. Transpl. 2010, 10:1556-1568.
40. Knosalla C., Yazawa K., Behdad A., Bodyak N., Shang H., Buhler L., et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am. J. Transpl. 2009, 9:1006-1016.
41. Byrne G.W., Davies W.R., Oi K., Rao V.P., Teotia S.S., Ricci D., et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 2006, 82:1787-1791.
42. Mohiuddin M.M., Singh A.K., Corcoran P.C., Hoyt R.F., Thomas M.L., Ayares D., et al. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J. Thorac. Cardiovasc Surg. 2014, 148:1106-1113. discussion 1113-1104.
43. Ezzelarab M.B., Ekser B., Azimzadeh A., Lin C.C., Zhao Y., Rodriguez R., et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation 2015, 22:32-47.
44. H. Iwase, B. Ekser, H. Zhou, H. Liu, V. Satyananda, R. Humar, et al., Further Evidence for a Sustained Systemic Inflammatory Response in Xenograft Recipients (SIXR), Submitted for publication.
45. Kuwaki K., Knosalla C., Dor F.J., Gollackner B., Tseng Y.L., Houser S., et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am. J. Transpl. 2004, 4:363-372.
46. Ekser B., Burlak C., Waldman J.P., Lutz A.J., Paris L.L., Veroux M., et al. Immunobiology of liver xenotransplantation. Expert Rev. Clin. Immunol. 2012, 8:621-634.
47. Harris D.G., Quinn K.J., French B.M., Schwartz E., Kang E., Dahi S., et al. Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation 2015, 22:102-111.
48. Cooper D.K., Satyananda V., Ekser B., Van der Windt D.J., Hara H., Ezzelarab M., et al. Progress in pig-to-nonhuman primate transplantation models (1998-2013): a comprehensive review of the literature. Xenotransplantation 2014, 21:397-419.
49. Padler-Karavani V., Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011, 18:1-5.
50. Byrne G.W., Du Z., Stalboerger P., Kogelberg H., McGregor C.G. Cloning and expression of porcine beta1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation 2014, 21:543-554.
51. Lutz A.J., Li P., Estrada J.L., Sidner R.A., Chihara R.K., Downey S.M., et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013, 20:27-35.
52. van der Windt D.J., Bottino R., Kumar G., Wijkstrom M., Hara H., Ezzelarab M., et al. Clinical islet xenotransplantation: how close are we?. Diabetes 2012, 61:3046-3055.
53. Bottino R., Wijkstrom M., van der Windt D.J., Hara H., Ezzelarab M., Murase N., et al. Pig-to-monkey islet xenotransplantation using multi-transgenic pigs. Am. J. Transpl. 2014, 14:2275-2287.
54. van der Windt D.J., Bottino R., Casu A., Campanile N., Smetanka C., He J., et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am. J. Transpl. 2009, 9:2716-2726.
55. Shin J.S., Kim J.M., Kim J.S., Min B.H., Kim Y.H., Kim H.J., et al. Long-term control of diabetes in imunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets. Am. J. Transpl. 1915, (Epub ahead or Print). 10.1111/ajt.13345.
56. Cardona K., Korbutt G.S., Milas Z., Lyon J., Cano J., Jiang W., et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 2006, 12:304-306.
57. Thompson P., Badell I.R., Lowe M., Cano J., Song M., Leopardi F., et al. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am. J. Transpl. 2011, 11:2593-2602.
58. Tseng Y.L., Sachs D.H., Cooper D.K. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress. Transplantation 2005, 79:1-9.
59. Tasaki M., Wamala I., Tena A., Villani V., Sekijima M., Pathiraja V., et al. High incidence of xenogenic bone marrow engraftment in pig-to-baboon intra-bone bone marrow transplantation. Am. J. Transpl. 2015, 15:974-983.